Effect of long-term intensive cholesterol control on the plaque progression in elderly based on CTA cohort study
- PMID: 35226154
- DOI: 10.1007/s00330-022-08594-w
Effect of long-term intensive cholesterol control on the plaque progression in elderly based on CTA cohort study
Abstract
Objectives: To investigate the long-term effects of intensive LDL cholesterol-lowering treatments on lumen stenosis severity, plaque calcification, spotty calcifications, percent calcified plaque volume (PCPV), and Agatston coronary artery calcium score (CACS) based on coronary computed tomography angiography (CCTA) in elderly patients.
Methods: A total of 240 patients over 60 years old (comprising 754 lesions) who underwent serial CCTA were retrospectively enrolled in this 5-year cohort study. Patients were divided into three groups: an intensive lipid-lowering group, a lipid-lowering group, and a control group. The stenosis severity, plaque volume (PV), plaque composition, PCPV, and high-risk plaque (HRP) presence were quantitatively analyzed. The CACS was calculated at baseline and follow-up.
Results: All patients were male with an average age of 66.8 ± 5.8 years old. Over time, increases in the percentages of obstructive coronary lesions (p < 0.001) were observed. Compared with those at baseline, the percentage of obstructive lesions remained unchanged (p = 0.077), and the percentage of spotty calcifications significantly decreased (p < 0.05) at the follow-up CCTA scan in the intensive lipid-lowering group. Patients in the intensive lipid-lowering group demonstrated a higher progression in calcified PV, CACS, and PCPV (all p < 0.05), and a significantly greater attenuation in fibrous-fatty and lipid-rich PV (all p < 0.05) than patients in other groups.
Conclusions: The PV and contents increased gradually with time in all groups. Intensive LDL-C lowering was associated with slower progression of stenosis severity and reduction of high-risk plaque features, with increased plaque calcification and higher progression in PCPV. Comprehensive serial plaque evaluations by CCTAs may contribute to further refinement of risk stratification and reasonable lipid-lowering treatment in elderly patients.
Key points: • Intensive LDL-C lowering increased coronary calcification and percent calcified plaque volume progression. • Comprehensive serial plaque evaluations by serial CCTAs may help to refine risk stratification.
Keywords: Atherosclerosis; Calcification, physiologic; Cholesterol, LDL; Computed tomography angiography; Coronary artery disease.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
The effect of LDL-C status on the association between increased coronary artery calcium score and compositional plaque volume progression in statins-treated diabetic patients: evaluated using serial coronary CTAs.Cardiovasc Diabetol. 2022 Jun 30;21(1):121. doi: 10.1186/s12933-022-01556-y. Cardiovasc Diabetol. 2022. PMID: 35773708 Free PMC article.
-
Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study.Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1307-1314. doi: 10.1093/ehjci/jez022. Eur Heart J Cardiovasc Imaging. 2019. PMID: 30789215 Free PMC article.
-
Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.JACC Cardiovasc Imaging. 2017 Apr;10(4):437-446. doi: 10.1016/j.jcmg.2016.04.013. Epub 2016 Oct 19. JACC Cardiovasc Imaging. 2017. PMID: 27771404
-
Bridging Prevention and Imaging: The Influence of Statins on CAC and CCTA Findings.Curr Atheroscler Rep. 2025 Apr 8;27(1):50. doi: 10.1007/s11883-025-01287-x. Curr Atheroscler Rep. 2025. PMID: 40198377 Review.
-
Utilizing (serial) coronary computed tomography angiography (CCTA) to predict plaque progression and major adverse cardiac events (MACE): results, merits and challenges.Eur Radiol. 2022 May;32(5):3408-3422. doi: 10.1007/s00330-021-08393-9. Epub 2022 Jan 8. Eur Radiol. 2022. PMID: 34997285 Review.
Cited by
-
A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement.Life Med. 2023 Sep 27;2(5):lnad035. doi: 10.1093/lifemedi/lnad035. eCollection 2023 Oct. Life Med. 2023. PMID: 39872891 Free PMC article.
-
Coronary computed tomography angiography-derived total coronary plaque burden associated with subsequent cardiovascular outcomes following percutaneous coronary intervention.Eur Radiol. 2024 Nov;34(11):7297-7308. doi: 10.1007/s00330-024-10784-7. Epub 2024 May 23. Eur Radiol. 2024. PMID: 38780767
-
Application of Quantitative Assessment of Coronary Atherosclerosis by Coronary Computed Tomographic Angiography.Korean J Radiol. 2024 Jun;25(6):518-539. doi: 10.3348/kjr.2023.1311. Korean J Radiol. 2024. PMID: 38807334 Free PMC article. Review.
-
The effect of LDL-C status on the association between increased coronary artery calcium score and compositional plaque volume progression in statins-treated diabetic patients: evaluated using serial coronary CTAs.Cardiovasc Diabetol. 2022 Jun 30;21(1):121. doi: 10.1186/s12933-022-01556-y. Cardiovasc Diabetol. 2022. PMID: 35773708 Free PMC article.
-
Vascular calcification: Molecular mechanisms and therapeutic interventions.MedComm (2020). 2023 Jan 3;4(1):e200. doi: 10.1002/mco2.200. eCollection 2023 Feb. MedComm (2020). 2023. PMID: 36620697 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical